Health Condition 1: null- Dementia
Conditions
Interventions
Intervention1: CurQfen: Bioavailable form of curcumin - The CurQfen, 500mg 2 times in a day for 180 days
Control Intervention1: Curcumin: Normal Curcumin 500mg ,2 times in a day for 180 days
Control I
Sponsors
Akay Flavours and Aromatics Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 55-75 Years ( Both Inclusive) 2.Male and Female Subjects 3.Patients with a MMSE Score Less than 26 and More than 14 (Both are Inclusive) 4.Must have a caregiver to attend the study visit. 5.Informed consent from Subject and Legally acceptable Representative-LAR( LAR can be Spouse/Parent/Son/Daughter/Guardian/Person Having charge or any other legally acceptable Representative)
Exclusion criteria
Exclusion criteria: 1.Severe Memory Loss 2.Stroke 3.Psychiatric illness 4.Subjects who are under the treatment with anti Inflammatory Drugs 5.Objection from family members or any other close relatives or Legally acceptable representatives 6.If the participation in the study cause any harm to possible benefits to the patients, including Insurance benefits. 7.Objection from the Physician, under whom, current treatment is going on. 8.Patients, who are in the Clinicians judgment, are like to be placed in a nursing home, within next 6 months 9.Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative changes in the MMSE, ACE-R, QOL,Beta Amyloid scores from baseline to Day 180.Timepoint: Day 0,Day 90,Day 180 | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparative changes in the anti oxidant, anti inflammatory and safety parameters from Day 0 To day 180Timepoint: Day 0. Day 90, Day 180 | — |
Countries
India
Contacts
Public ContactJestin V Thomas
Akay Flavours and Aromatics Private Limited
Outcome results
None listed